Slim Fast, other supplements recalled
This article was originally published in The Tan Sheet
Executive Summary
Supplement firm Universal ABC Beauty Supply International voluntarily recalls 34 products found by FDA to contain an undeclared substance, sibutramine, a prescription weight-loss drug, the Brooklyn, N.Y.-based company says in an April 20 release. The products, including Slim Fast, ProSlim, and Slim 3in1 formulas, have not been approved by the agency and the ingredient is known to potentially cause cardiovascular issues in some users, the firm notes. When FDA announed a crackdown on adulterated weight-loss products in January, the agency warned that selling unapproved drugs may lead to criminal action, though it did not identify the firms suspected of marketing the products (1"The Tan Sheet" Jan. 5, 2009, p. 8). Universal's recalled products were on FDA's list of more than 70 products identified as tainted with undeclared drugs. Only three products had been recalled through April 8, FDA said
You may also be interested in...
FDA Warns Of Possible Criminal Charges Against Weight-Loss Product Firms
FDA's enforcement action against 28 weight-loss products found to contain undeclared pharmaceutical ingredients drew applause from GlaxoSmithKline, marketer of alli, the only OTC drug approved for weight loss in the U.S
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.